Basket evidence

XRPUSDT Aggressive Wave18

Published RA-Trader basket simulation evidence for XRPUSDT aggressive. This is historical simulation evidence, not an investment promise.

Metrics

15,474.23%historical simulation return
-17.3%maximum drawdown
2.66profit factor
55.41%win rate across 388 trades

Tested window: 2025-01-12 to 2026-01-12. Starting balance: 10,000. Ending balance: 1,557,423.04.

Included Strategy Modules

Strategy IDTimeframeFamily
mean_reversion_zscore#v080e7f4bb5@rr_struct_pd240mean_reversion_zscore#v080e7f4bb5@rr_struct_pd
marubozu_impulse_followthrough#v600b070f19@rr260marubozu_impulse_followthrough#v600b070f19@rr2
mean_reversion_zscore#ve2b87074e0@rr_struct_pd240mean_reversion_zscore#ve2b87074e0@rr_struct_pd
equal_high_low_liquidity_raid#v2d71c33b9a@rr_struct_pd240equal_high_low_liquidity_raid#v2d71c33b9a@rr_struct_pd
breakout_range#v10feeecc3f@rr_struct_pd240breakout_range#v10feeecc3f@rr_struct_pd
inside_bar_previous_day_break#v95bae85391@rr2240inside_bar_previous_day_break#v95bae85391@rr2
mean_reversion_zscore#vc8edc310ca@rr_struct_pd240mean_reversion_zscore#vc8edc310ca@rr_struct_pd
inside_bar_fakey_reversal#v492fc61697@rr2240inside_bar_fakey_reversal#v492fc61697@rr2
equal_high_low_liquidity_raid#v71077cfaec@rr_struct_pd240equal_high_low_liquidity_raid#v71077cfaec@rr_struct_pd
inside_bar_session_breakout#vdfba2c2a69@rr_struct_pd240inside_bar_session_breakout#vdfba2c2a69@rr_struct_pd
equal_high_low_liquidity_raid#v4d3b6fbab1@rr2240equal_high_low_liquidity_raid#v4d3b6fbab1@rr2
breakout_range#v1eb8ffbf58@rr_struct_pd240breakout_range#v1eb8ffbf58@rr_struct_pd

Monthly Returns

MonthReturn
2025-0166.09%
2025-02183.88%
2025-03113.11%
2025-0448.35%
2025-052.18%
2025-0655.66%
2025-07-5.37%
2025-0834.76%
2025-090.62%
2025-1079.22%
2025-11117.11%
2025-127.66%
2026-0122.22%

Past Performance Disclaimer

Historical simulations/backtests can fail in live trading because of market regime changes, slippage, fees, exchange outages, liquidity, and user configuration. This page is evidence, not investment advice.